Article(id=1329527182713532982, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329527047069741522, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2024.05.014, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1701100800000, receivedDateStr=2023-11-28, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794913581779, onlineDateStr=2026-11-17, pubDate=1715270400000, pubDateStr=2024-05-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794913581779, onlineIssueDateStr=2026-11-17, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794913581779, creator=13701087609, updateTime=1794913581779, updator=13701087609, issue=Issue{id=1329527047069741522, tenantId=1146029695717560320, journalId=1319690329412173987, year='2024', volume='45', issue='5', pageStart='449', pageEnd='566', issueExtLink='null', onlineDate='null', pubDate='1715270400000', pubDateStr='2024-05-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794913549438, creator='13701087609', updateTime=1794962129197, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329730805833773281, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329527047069741522, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329730805833773282, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329527047069741522, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=530, endPage=536, ext={EN=ArticleExt(id=1329527182948414007, articleId=1329527182713532982, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=The mechanism of immune system action in non-alcoholic fatty liver disease and the prospects for stem cell therapy, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Nonalcoholic fatty liver disease (NAFLD), as a widespread chronic hepatic disease, is caused by the accumulation of hepatocellular triglyceride, instigating immunological engagement and accompanied by histopathological alterations. NAFLD's a progressive ailment, and the inflammatory response is the driving force in the progression of NAFLD, with various triggers involving metabolic damage often leading to the activation of different immunocytes. The specific drug for NAFLD remains deficient. Stem cell-derived exosomes, representing an innovative therapeutic modality with minimized immunogenicity, are used to suppress the immune reactions in tissues. This article aimed to explore the pathogenesis of NAFLD and the importance of liver in human immunity, discuss the role of different immunocytes in the pathogenesis and progression of NAFLD, deeply understand the pathogenesis of immunocytes involved in NAFLD, summarize the current immunotherapy, and to provide theoretical support for the design of new immunotherapy.

, authors=Xin BAI1, 2, Minyu LIU1, 2, *, authorsList=Xin BAI, Minyu LIU, authorCompany=null, correspAuthors=Minyu LIU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329527183221043768, articleId=1329527182713532982, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=非酒精性脂肪肝病中的免疫作用及干细胞疗法的前景, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=

非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD)作为普遍的慢性肝脏疾病,由肝细胞内三酰甘油聚集引发免疫系统参与,并伴随组织学改变。NAFLD是一种进展性疾病,炎症反应被认为是NAFLD进展的驱动力,涉及代谢损伤的各种触发因素通常会导致不同免疫细胞的激活。针对NAFLD的特异性药物治疗仍然缺乏。来自干细胞的外泌体是一种低免疫原性的新型疗法,被用来抑制组织中的免疫反应。该文旨在探究NAFLD的发病机制以及肝脏对人体免疫的重要性,重点讨论不同免疫细胞在NAFLD发病及进展中的作用,深层次理解免疫细胞参与NAFLD的发病机制,对目前免疫疗法进行总结,为设计新的免疫疗法提供理论支撑。

, authors=白鑫1, 2, 刘珉宇1, 2, *, authorsList=白鑫, 刘珉宇, authorCompany=null, correspAuthors=刘珉宇, authorNote=

白鑫,硕士研究生,研究方向:代谢相关疾病的新药研发。

, correspAuthorsNote=
刘珉宇,研究员,博士生导师,研究方向:自身免疫性疾病、代谢相关疾病的新药研发。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=8uiI7OJPyude2FBjXXGaOQ==, magXml=tPi1B5d0T9w31gQJvKhauw==, pdfUrl=null, pdf=o3/Fi9FSYhTI50J1zzxBQA==, pdfFileSize=1580693, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=8GdeXKXuDmPmqBqcKLHyjg==, mapNumber=null, fund=null)}, authors=[Author(id=1329527183606919744, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527183690805827, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, authorId=1329527183606919744, language=EN, stringName=Xin BAI, firstName=Xin, middleName=null, lastName=BAI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.State Key Laboratory of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
2.Shanghai Professional and Technical Service Center for Biological Material Drug-ability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527183753720388, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, authorId=1329527183606919744, language=CN, stringName=白鑫, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437
2.上海市生物物质成药性评价技术服务平台,上海 200437, bio={"content":"

白鑫,硕士研究生,研究方向:代谢相关疾病的新药研发。

"}, bioImg=null, bioContent=

白鑫,硕士研究生,研究方向:代谢相关疾病的新药研发。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527183413981753, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, xref=1., ext=[AuthorCompanyExt(id=1329527183422370362, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, companyId=1329527183413981753, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.State Key Laboratory of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329527183426564667, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, companyId=1329527183413981753, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437)]), AuthorCompany(id=1329527183518839356, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, xref=2., ext=[AuthorCompanyExt(id=1329527183527227965, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, companyId=1329527183518839356, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Professional and Technical Service Center for Biological Material Drug-ability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329527183535616574, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, companyId=1329527183518839356, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海市生物物质成药性评价技术服务平台,上海 200437)])]), Author(id=1329527183820829254, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329527183908909641, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, authorId=1329527183820829254, language=EN, stringName=Minyu LIU, firstName=Minyu, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.State Key Laboratory of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
2.Shanghai Professional and Technical Service Center for Biological Material Drug-ability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527183984407114, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, authorId=1329527183820829254, language=CN, stringName=刘珉宇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437
2.上海市生物物质成药性评价技术服务平台,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527183413981753, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, xref=1., ext=[AuthorCompanyExt(id=1329527183422370362, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, companyId=1329527183413981753, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.State Key Laboratory of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329527183426564667, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, companyId=1329527183413981753, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437)]), AuthorCompany(id=1329527183518839356, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, xref=2., ext=[AuthorCompanyExt(id=1329527183527227965, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, companyId=1329527183518839356, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Professional and Technical Service Center for Biological Material Drug-ability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329527183535616574, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, companyId=1329527183518839356, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海市生物物质成药性评价技术服务平台,上海 200437)])])], keywords=[Keyword(id=1329527185632768587, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, language=EN, orderNo=1, keyword=immune response), Keyword(id=1329527185708266060, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, language=EN, orderNo=2, keyword=non-alcoholic fatty liver disease), Keyword(id=1329527185779569229, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, language=EN, orderNo=3, keyword=stem cell exosomes), Keyword(id=1329527185846678094, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, language=EN, orderNo=4, keyword=immunotherapy), Keyword(id=1329527185913786959, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, language=CN, orderNo=1, keyword=免疫反应), Keyword(id=1329527185989284432, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, language=CN, orderNo=2, keyword=非酒精性脂肪肝病), Keyword(id=1329527186056393297, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, language=CN, orderNo=3, keyword=干细胞外泌体), Keyword(id=1329527186131890770, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, language=CN, orderNo=4, keyword=免疫疗法)], refs=[Reference(id=1329527186224165459, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Targher G, Byrne CD, Tilg H. MASLD: A systemic metabolic disorder with cardiovascular and malignant complications[J]. Gut, 2024, 73(4): 691-702., articleTitle=null, refAbstract=null), Reference(id=1329527186299662932, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Gofton C, Upendran Y, Zheng MH, et al. MAFLD: How is it different from NAFLD?[J]. Clin Mol Hepatol, 2023, 29(Suppl): S17-S31., articleTitle=null, refAbstract=null), Reference(id=1329527186366771797, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Younossi ZM, Golabi P, Paik JM, et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review[J]. Hepatology, 2023, 77(4): 1335-1347., articleTitle=null, refAbstract=null), Reference(id=1329527186438074966, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Pouwels S, Sakran N, Graham Y, et al. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss[J]. Bio Med Central Endocrine Disorders, 2022, 22(1): 63., articleTitle=null, refAbstract=null), Reference(id=1329527186521961047, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Peiseler M, Kubes P. More friend than foe: the emerging role of neutrophils in tissue repair[J]. J Clin Invest, 2019, 129(7): 2629-2639., articleTitle=null, refAbstract=null), Reference(id=1329527186597458520, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Wu L, Gao X, Guo Q, et al. The role of neutrophils in innate immunity-driven nonalcoholic steatohepatitis: lessons learned and future promise[J]. Hepatol Int, 2020, 14(5): 652-666., articleTitle=null, refAbstract=null), Reference(id=1329527186668761689, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Friedman SL, Neuschwander-Tetri BA, Rinella M, et al. Mechanisms of NAFLD development and therapeutic strategies[J]. Nat Med, 2018, 24(7): 908-922., articleTitle=null, refAbstract=null), Reference(id=1329527186740064858, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Liu X, Xia S, Zhang Z, et al. Channelling inflammation: gasdermins in physiology and disease[J]. Nat Rev Drug Discov, 2021, 20(5): 384-405., articleTitle=null, refAbstract=null), Reference(id=1329527186815562331, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Yu L, Hong W, Lu S, et al. The NLRP3 inflammasome in non-alcoholic fatty liver disease and steatohepatitis: therapeutic targets and treatment[J]. Front Pharmacol, 2022, 13: 780496., articleTitle=null, refAbstract=null), Reference(id=1329527186886865500, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Kubes P, Jenne C. Immune responses in the liver[J]. Ann Rev Immunol, 2018, 36(1): 247-277., articleTitle=null, refAbstract=null), Reference(id=1329527186974945885, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Bartsch LM, Damasio MPS, Subudhi S, et al. Tissue-resident memory T cells in the liver - unique characteristics of local specialists[J]. Cells, 2020, 9(11): 2457., articleTitle=null, refAbstract=null), Reference(id=1329527187058831966, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Govaere O, Petersen SK, Martinez-Lopez N, et al. Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease[J]. J Hepatol, 2022, 76(5): 1001-1012., articleTitle=null, refAbstract=null), Reference(id=1329527187138523743, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Carranza-Trejo AM, Vetvicka V, Vistejnova L, et al. Hepatocyte and immune cell crosstalk in non-alcoholic fatty liver disease[J]. Exp Rev Gastroenterol Hepatol, 2021, 15(7): 783-796., articleTitle=null, refAbstract=null), Reference(id=1329527187247575648, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Giles DA, Moreno-Fernandez ME, Stankiewicz TE, et al. Regulation of inflammation by IL-17A and IL-17F modulates non-alcoholic fatty liver disease pathogenesis[J]. PLoS One, 2016, 11(2): e0149783., articleTitle=null, refAbstract=null), Reference(id=1329527187360821857, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Huby T, Gautier EL. Immune cell-mediated features of non-alcoholic steatohepatitis[J]. Nat Rev Immunol, 2021, 22(7): 429-443., articleTitle=null, refAbstract=null), Reference(id=1329527187465679458, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Heier EC, Meier A, Julich-Haertel H, et al. Murine CD103+ dendritic cells protect against steatosis progression towards steatohepatitis[J]. J Hepatol, 2017, 66(6): 1241-1250., articleTitle=null, refAbstract=null), Reference(id=1329527187536982627, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Deczkowska A, David E, Ramadori P, et al. Publisher correction: XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis[J]. Nat Med, 2022, 28(1): 214., articleTitle=null, refAbstract=null), Reference(id=1329527187625063012, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Ibrahim J, Nguyen AH, Rehman A, et al. Dendritic cell populations with different concentrations of lipid regulate tolerance and immunity in mouse and human liver[J]. Gastroenterology, 2012, 143(4): 1061-1072., articleTitle=null, refAbstract=null), Reference(id=1329527187734114917, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhang X, Ji L, Li MO. Control of tumor-associated macrophage responses by nutrient acquisition and metabolism[J]. Immunity, 2023, 56(1): 14-31., articleTitle=null, refAbstract=null), Reference(id=1329527187826389606, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Tran S, Baba I, Poupel L, et al. Impaired Kupffer cell self-renewal alters the liver response to lipid overload during non-alcoholic steatohepatitis[J]. Immunity, 2020, 53(3): 627-640., articleTitle=null, refAbstract=null), Reference(id=1329527187914469991, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Seidman JS, Troutman TD, Sakai M, et al. Niche-specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis[J]. Immunity, 2020, 52(6): 1057-1074., articleTitle=null, refAbstract=null), Reference(id=1329527187998356072, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=He S, Cui S, Song W, et al. Interleukin-17 weakens the NAFLD/NASH process by facilitating intestinal barrier restoration depending on the gut microbiota[J]. mBio, 2022, 13(2): e0368821., articleTitle=null, refAbstract=null), Reference(id=1329527188078047849, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Xu R, Tao A, Zhang S, et al. Neutralization of interleukin-17 attenuates high fat diet-induced non-alcoholic fatty liver disease in mice[J]. Acta Biochim Biophys Sin (Shanghai), 2013, 45(9): 726-733., articleTitle=null, refAbstract=null), Reference(id=1329527188166128234, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Liu B, Tian Y, He J, et al. The potential of mecciRNA in hepatic stellate cell to regulate progression of nonalcoholic hepatitis[J]. J Transl Med, 2022, 20(1): 393., articleTitle=null, refAbstract=null), Reference(id=1329527188254208619, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Martínez-Chantar ML, Delgado TC, Beraza N. Revisiting the role of natural killer cells in non-alcoholic fatty liver disease[J]. Front Immunol, 2021, 12: 640869., articleTitle=null, refAbstract=null), Reference(id=1329527188346483308, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Gu X, Chu Q, Ma X, et al. New insights into iNKT cells and their roles in liver disease[J]. Front Immunol, 2022, 13: 1035950., articleTitle=null, refAbstract=null), Reference(id=1329527188421980781, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Sutti S, Albano E. Adaptive immunity: an emerging player in the progression of NAFLD[J]. Nat Rev Gastroenterol Hepatol, 2019, 17(2): 81-92., articleTitle=null, refAbstract=null), Reference(id=1329527188543615598, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Barrow F, Khan S, Wang H, et al. The emerging role of B cells in the pathogenesis of NAFLD[J]. Hepatology, 2021, 74(4): 2277-2286., articleTitle=null, refAbstract=null), Reference(id=1329527190179394159, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Wiering L, Tacke F. Treating inflammation to combat non-alcoholic fatty liver disease[J]. J Endocrinol, 2023, 256(1): e220194., articleTitle=null, refAbstract=null), Reference(id=1329527190271668848, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhou C, Zhang B, Yang Y, et al. Stem cell-derived exosomes: emerging therapeutic opportunities for wound healing[J]. Stem Cell Res Ther, 2023, 14(1): 107., articleTitle=null, refAbstract=null), Reference(id=1329527190359749233, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhu M, Hua T, Ouyang T, et al. Applications of mesenchymal stem cells in liver fibrosis: novel strategies, mechanisms, and clinical practice[J]. Stem Cells Int, 2021, 2021: 6546780., articleTitle=null, refAbstract=null), Reference(id=1329527190447829618, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Kostallari E, Valainathan S, Biquard L, et al. Role of extracellular vesicles in liver diseases and their therapeutic potential[J]. Adv Drug Deliv Rev, 2021, 175: 113816., articleTitle=null, refAbstract=null), Reference(id=1329527190535910003, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Bi Y, Guo X, Zhang M, et al. Bone marrow derived-mesenchymal stem cell improves diabetes-associated fatty liver via mitochondria transformation in mice[J]. Stem Cell Res Ther, 2021, 12(1): 602B., articleTitle=null, refAbstract=null), Reference(id=1329527190611407476, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhou X, Kalluri R. Biology and therapeutic potential of mesenchymal stem cell-derived exosomes[J]. Cancer Sci, 2020, 111(9): 3100-3110., articleTitle=null, refAbstract=null), Reference(id=1329527190682710645, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=Dorairaj V, Sulaiman SA, Abu N, et al. Extracellular vesicles in the development of the non-alcoholic fatty liver disease: an update[J]. Biomolecules, 2020, 10(11): 1494., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329527183413981753, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, xref=1., ext=[AuthorCompanyExt(id=1329527183422370362, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, companyId=1329527183413981753, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.State Key Laboratory of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329527183426564667, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, companyId=1329527183413981753, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437)]), AuthorCompany(id=1329527183518839356, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, xref=2., ext=[AuthorCompanyExt(id=1329527183527227965, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, companyId=1329527183518839356, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Professional and Technical Service Center for Biological Material Drug-ability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329527183535616574, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, companyId=1329527183518839356, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海市生物物质成药性评价技术服务平台,上海 200437)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.05.014, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.05.014, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2024.05.014, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2024.05.014, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1715270400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
非酒精性脂肪肝病中的免疫作用及干细胞疗法的前景
白鑫 1, 2 , 刘珉宇 1, 2, *
世界临床药物 | 综述评论 2024,45(5): 530-536
收起
收藏切换
世界临床药物 |综述评论 2024 , 45 (5) : 530 -536
非酒精性脂肪肝病中的免疫作用及干细胞疗法的前景
全屏
[Author(id=1329527183606919744, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527183690805827, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, authorId=1329527183606919744, language=EN, stringName=Xin BAI, firstName=Xin, middleName=null, lastName=BAI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.State Key Laboratory of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
2.Shanghai Professional and Technical Service Center for Biological Material Drug-ability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527183753720388, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, authorId=1329527183606919744, language=CN, stringName=白鑫, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437
2.上海市生物物质成药性评价技术服务平台,上海 200437, bio={"content":"

白鑫,硕士研究生,研究方向:代谢相关疾病的新药研发。

"}, bioImg=null, bioContent=

白鑫,硕士研究生,研究方向:代谢相关疾病的新药研发。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527183413981753, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, xref=1., ext=[AuthorCompanyExt(id=1329527183422370362, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, companyId=1329527183413981753, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.State Key Laboratory of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329527183426564667, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, companyId=1329527183413981753, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437)]), AuthorCompany(id=1329527183518839356, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, xref=2., ext=[AuthorCompanyExt(id=1329527183527227965, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, companyId=1329527183518839356, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Professional and Technical Service Center for Biological Material Drug-ability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329527183535616574, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, companyId=1329527183518839356, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海市生物物质成药性评价技术服务平台,上海 200437)])]), Author(id=1329527183820829254, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329527183908909641, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, authorId=1329527183820829254, language=EN, stringName=Minyu LIU, firstName=Minyu, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.State Key Laboratory of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
2.Shanghai Professional and Technical Service Center for Biological Material Drug-ability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527183984407114, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, authorId=1329527183820829254, language=CN, stringName=刘珉宇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437
2.上海市生物物质成药性评价技术服务平台,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527183413981753, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, xref=1., ext=[AuthorCompanyExt(id=1329527183422370362, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, companyId=1329527183413981753, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.State Key Laboratory of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329527183426564667, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, companyId=1329527183413981753, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437)]), AuthorCompany(id=1329527183518839356, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, xref=2., ext=[AuthorCompanyExt(id=1329527183527227965, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, companyId=1329527183518839356, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Professional and Technical Service Center for Biological Material Drug-ability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329527183535616574, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527182713532982, companyId=1329527183518839356, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海市生物物质成药性评价技术服务平台,上海 200437)])])]
白鑫1, 2, 刘珉宇1, 2, *
作者信息
  • 1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437
  • 2.上海市生物物质成药性评价技术服务平台,上海 200437
通讯作者:
刘珉宇,研究员,博士生导师,研究方向:自身免疫性疾病、代谢相关疾病的新药研发。
作者简介:

白鑫,硕士研究生,研究方向:代谢相关疾病的新药研发。

The mechanism of immune system action in non-alcoholic fatty liver disease and the prospects for stem cell therapy
Xin BAI1, 2, Minyu LIU1, 2, *
Affiliations
  • 1.State Key Laboratory of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
  • 2.Shanghai Professional and Technical Service Center for Biological Material Drug-ability Evaluation, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
出版时间: 2024-05-10 doi: 10.13683/j.wph.2024.05.014
文章导航
收藏切换

非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD)作为普遍的慢性肝脏疾病,由肝细胞内三酰甘油聚集引发免疫系统参与,并伴随组织学改变。NAFLD是一种进展性疾病,炎症反应被认为是NAFLD进展的驱动力,涉及代谢损伤的各种触发因素通常会导致不同免疫细胞的激活。针对NAFLD的特异性药物治疗仍然缺乏。来自干细胞的外泌体是一种低免疫原性的新型疗法,被用来抑制组织中的免疫反应。该文旨在探究NAFLD的发病机制以及肝脏对人体免疫的重要性,重点讨论不同免疫细胞在NAFLD发病及进展中的作用,深层次理解免疫细胞参与NAFLD的发病机制,对目前免疫疗法进行总结,为设计新的免疫疗法提供理论支撑。

免疫反应  /  非酒精性脂肪肝病  /  干细胞外泌体  /  免疫疗法

Nonalcoholic fatty liver disease (NAFLD), as a widespread chronic hepatic disease, is caused by the accumulation of hepatocellular triglyceride, instigating immunological engagement and accompanied by histopathological alterations. NAFLD's a progressive ailment, and the inflammatory response is the driving force in the progression of NAFLD, with various triggers involving metabolic damage often leading to the activation of different immunocytes. The specific drug for NAFLD remains deficient. Stem cell-derived exosomes, representing an innovative therapeutic modality with minimized immunogenicity, are used to suppress the immune reactions in tissues. This article aimed to explore the pathogenesis of NAFLD and the importance of liver in human immunity, discuss the role of different immunocytes in the pathogenesis and progression of NAFLD, deeply understand the pathogenesis of immunocytes involved in NAFLD, summarize the current immunotherapy, and to provide theoretical support for the design of new immunotherapy.

immune response  /  non-alcoholic fatty liver disease  /  stem cell exosomes  /  immunotherapy
白鑫, 刘珉宇. 非酒精性脂肪肝病中的免疫作用及干细胞疗法的前景. 世界临床药物, 2024 , 45 (5) : 530 -536 . DOI: 10.13683/j.wph.2024.05.014
Xin BAI, Minyu LIU. The mechanism of immune system action in non-alcoholic fatty liver disease and the prospects for stem cell therapy[J]. World Clinical Drug, 2024 , 45 (5) : 530 -536 . DOI: 10.13683/j.wph.2024.05.014

参考文献 引证文献
排序方式:
[1]
Targher G, Byrne CD, Tilg H. MASLD: A systemic metabolic disorder with cardiovascular and malignant complications[J]. Gut, 2024, 73(4): 691-702.
[2]
Gofton C, Upendran Y, Zheng MH, et al. MAFLD: How is it different from NAFLD?[J]. Clin Mol Hepatol, 2023, 29(Suppl): S17-S31.
[3]
Younossi ZM, Golabi P, Paik JM, et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review[J]. Hepatology, 2023, 77(4): 1335-1347.
[4]
Pouwels S, Sakran N, Graham Y, et al. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss[J]. Bio Med Central Endocrine Disorders, 2022, 22(1): 63.
[5]
Peiseler M, Kubes P. More friend than foe: the emerging role of neutrophils in tissue repair[J]. J Clin Invest, 2019, 129(7): 2629-2639.
[6]
Wu L, Gao X, Guo Q, et al. The role of neutrophils in innate immunity-driven nonalcoholic steatohepatitis: lessons learned and future promise[J]. Hepatol Int, 2020, 14(5): 652-666.
[7]
Friedman SL, Neuschwander-Tetri BA, Rinella M, et al. Mechanisms of NAFLD development and therapeutic strategies[J]. Nat Med, 2018, 24(7): 908-922.
[8]
Liu X, Xia S, Zhang Z, et al. Channelling inflammation: gasdermins in physiology and disease[J]. Nat Rev Drug Discov, 2021, 20(5): 384-405.
[9]
Yu L, Hong W, Lu S, et al. The NLRP3 inflammasome in non-alcoholic fatty liver disease and steatohepatitis: therapeutic targets and treatment[J]. Front Pharmacol, 2022, 13: 780496.
[10]
Kubes P, Jenne C. Immune responses in the liver[J]. Ann Rev Immunol, 2018, 36(1): 247-277.
[11]
Bartsch LM, Damasio MPS, Subudhi S, et al. Tissue-resident memory T cells in the liver - unique characteristics of local specialists[J]. Cells, 2020, 9(11): 2457.
[12]
Govaere O, Petersen SK, Martinez-Lopez N, et al. Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease[J]. J Hepatol, 2022, 76(5): 1001-1012.
[13]
Carranza-Trejo AM, Vetvicka V, Vistejnova L, et al. Hepatocyte and immune cell crosstalk in non-alcoholic fatty liver disease[J]. Exp Rev Gastroenterol Hepatol, 2021, 15(7): 783-796.
[14]
Giles DA, Moreno-Fernandez ME, Stankiewicz TE, et al. Regulation of inflammation by IL-17A and IL-17F modulates non-alcoholic fatty liver disease pathogenesis[J]. PLoS One, 2016, 11(2): e0149783.
[15]
Huby T, Gautier EL. Immune cell-mediated features of non-alcoholic steatohepatitis[J]. Nat Rev Immunol, 2021, 22(7): 429-443.
[16]
Heier EC, Meier A, Julich-Haertel H, et al. Murine CD103+ dendritic cells protect against steatosis progression towards steatohepatitis[J]. J Hepatol, 2017, 66(6): 1241-1250.
[17]
Deczkowska A, David E, Ramadori P, et al. Publisher correction: XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis[J]. Nat Med, 2022, 28(1): 214.
[18]
Ibrahim J, Nguyen AH, Rehman A, et al. Dendritic cell populations with different concentrations of lipid regulate tolerance and immunity in mouse and human liver[J]. Gastroenterology, 2012, 143(4): 1061-1072.
[19]
Zhang X, Ji L, Li MO. Control of tumor-associated macrophage responses by nutrient acquisition and metabolism[J]. Immunity, 2023, 56(1): 14-31.
[20]
Tran S, Baba I, Poupel L, et al. Impaired Kupffer cell self-renewal alters the liver response to lipid overload during non-alcoholic steatohepatitis[J]. Immunity, 2020, 53(3): 627-640.
[21]
Seidman JS, Troutman TD, Sakai M, et al. Niche-specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis[J]. Immunity, 2020, 52(6): 1057-1074.
[22]
He S, Cui S, Song W, et al. Interleukin-17 weakens the NAFLD/NASH process by facilitating intestinal barrier restoration depending on the gut microbiota[J]. mBio, 2022, 13(2): e0368821.
[23]
Xu R, Tao A, Zhang S, et al. Neutralization of interleukin-17 attenuates high fat diet-induced non-alcoholic fatty liver disease in mice[J]. Acta Biochim Biophys Sin (Shanghai), 2013, 45(9): 726-733.
[24]
Liu B, Tian Y, He J, et al. The potential of mecciRNA in hepatic stellate cell to regulate progression of nonalcoholic hepatitis[J]. J Transl Med, 2022, 20(1): 393.
[25]
Martínez-Chantar ML, Delgado TC, Beraza N. Revisiting the role of natural killer cells in non-alcoholic fatty liver disease[J]. Front Immunol, 2021, 12: 640869.
[26]
Gu X, Chu Q, Ma X, et al. New insights into iNKT cells and their roles in liver disease[J]. Front Immunol, 2022, 13: 1035950.
[27]
Sutti S, Albano E. Adaptive immunity: an emerging player in the progression of NAFLD[J]. Nat Rev Gastroenterol Hepatol, 2019, 17(2): 81-92.
[28]
Barrow F, Khan S, Wang H, et al. The emerging role of B cells in the pathogenesis of NAFLD[J]. Hepatology, 2021, 74(4): 2277-2286.
[29]
Wiering L, Tacke F. Treating inflammation to combat non-alcoholic fatty liver disease[J]. J Endocrinol, 2023, 256(1): e220194.
[30]
Zhou C, Zhang B, Yang Y, et al. Stem cell-derived exosomes: emerging therapeutic opportunities for wound healing[J]. Stem Cell Res Ther, 2023, 14(1): 107.
[31]
Zhu M, Hua T, Ouyang T, et al. Applications of mesenchymal stem cells in liver fibrosis: novel strategies, mechanisms, and clinical practice[J]. Stem Cells Int, 2021, 2021: 6546780.
[32]
Kostallari E, Valainathan S, Biquard L, et al. Role of extracellular vesicles in liver diseases and their therapeutic potential[J]. Adv Drug Deliv Rev, 2021, 175: 113816.
[33]
Bi Y, Guo X, Zhang M, et al. Bone marrow derived-mesenchymal stem cell improves diabetes-associated fatty liver via mitochondria transformation in mice[J]. Stem Cell Res Ther, 2021, 12(1): 602B.
[34]
Zhou X, Kalluri R. Biology and therapeutic potential of mesenchymal stem cell-derived exosomes[J]. Cancer Sci, 2020, 111(9): 3100-3110.
[35]
Dorairaj V, Sulaiman SA, Abu N, et al. Extracellular vesicles in the development of the non-alcoholic fatty liver disease: an update[J]. Biomolecules, 2020, 10(11): 1494.
2024年第45卷第5期
18
4
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2024.05.014
  • 接收时间:2023-11-28
  • 首发时间:2026-11-17
  • 出版时间:2024-05-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-11-28
基金
作者信息
    1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437
    2.上海市生物物质成药性评价技术服务平台,上海 200437

通讯作者:

刘珉宇,研究员,博士生导师,研究方向:自身免疫性疾病、代谢相关疾病的新药研发。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.05.014
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏